Innovent Biologics 2025 Interim Results Advancing toward a New Era of Growth and Global Innovation August 2025 Agenda and Speakers | Business Review and Outlook | Dr. Michael Yu | Founder, Chairman of the Board, CEO | | --- | --- | --- | | R&D Highlight Updates | Dr. Hui Zhou Dr. Lei Qian | Chief R&D Officer, Oncology Chief R&D Officer, General Biomedicine | | Financials and Summary | Ms. Rachel You | Chief Financial Officer | | Q&A | Management Team | | Confidential Copyright© 2025 Innovent 2025H1: Continu ...